International Stem Cell Corp. (OTCMKTS:ISCO – Get Free Report)’s stock price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.14 and traded as high as $0.1538. International Stem Cell shares last traded at $0.1456, with a volume of 1,901 shares traded.
International Stem Cell Trading Down 9.0%
The business’s 50-day simple moving average is $0.14 and its 200-day simple moving average is $0.14. The company has a market capitalization of $1.17 million, a PE ratio of -3.64 and a beta of -0.03.
About International Stem Cell
International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury.
Read More
- Five stocks we like better than International Stem Cell
- NYSE Stocks Give Investors a Variety of Quality Options
- Whirlpool’s Worst May Be Over—Upside Opportunity Ahead
- High Dividend REITs: Are They an Ideal Way to Diversify?
- These 3 Beaten-Down Stocks Could Be Your Best Buying Opportunity This Quarter
- 3 Fintech Stocks With Good 2021 Prospects
- How Does D-Wave Stack Up to Quantum Rivals After Earnings Season?
Receive News & Ratings for International Stem Cell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Stem Cell and related companies with MarketBeat.com's FREE daily email newsletter.
